Contrave Heart Benefits Are Unproven, FDA Restrictions Should be Added to Obesity Drug: Editorial
The new weight loss drug Contrave is under close scrutiny over a failed clinical trial whose results were prematurely released, improperly suggesting it had cardiovascular benefits.